MMUT
Basic information
Region (hg38): 6:49430360-49463253
Previous symbols: [ "MUT" ]
Links
Phenotypes
GenCC
Source:
- methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (Definitive), mode of inheritance: AR
- vitamin B12-unresponsive methylmalonic acidemia type mut- (Supportive), mode of inheritance: AR
- vitamin B12-unresponsive methylmalonic acidemia type mut0 (Supportive), mode of inheritance: AR
- methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (Strong), mode of inheritance: AR
- methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Methylmalonic acidemia due to methylmalonyl-CoA mutase deficiency | AR | Biochemical | Long-term dietary (high-calorie diet low in propiogenic amino acid precursors with carnitine supplementation) and medical management (eg, IM hydroxocobalamin, antibiotics to decrease propionate production) is indicated; Fasting and high-protein consumption should be avoided; In the emergent setting, prompt recognition and appropriate metabolic care may be beneficial to decrease morbidity and mortality; Antioxidants for optic nerve atrophy may be beneficial; Liver/kidney transplant has been described in methylmalonic acidemia | Biochemical; Hematologic; Cardiovascular; Neurologic; Ophthalmologic | 6132336; 1977311; 1970180; 1968706; 1346616; 1351030; 7681251; 15643616; 12948746; 16451139; 18563634; 20301409; 22614770; 22695176 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (152 variants)
- Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (96 variants)
- Methylmalonic acidemia (40 variants)
- Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency (35 variants)
- METHYLMALONIC ACIDURIA, mut(0) TYPE (9 variants)
- Abnormality of metabolism/homeostasis (2 variants)
- METHYLMALONIC ACIDURIA, mut(-) TYPE (2 variants)
- not specified (1 variants)
- Neonatal encephalopathy (1 variants)
- See cases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MMUT gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 214 | 218 | ||||
missense | 61 | 82 | 169 | 321 | ||
nonsense | 43 | 27 | 70 | |||
start loss | 1 | |||||
frameshift | 64 | 18 | 83 | |||
inframe indel | 8 | |||||
splice donor/acceptor (+/-2bp) | 18 | 14 | 33 | |||
splice region | 1 | 2 | 8 | 38 | 1 | 50 |
non coding | 29 | 117 | 25 | 174 | ||
Total | 190 | 146 | 204 | 337 | 31 |
Highest pathogenic variant AF is 0.000197
Variants in MMUT
This is a list of pathogenic ClinVar variants found in the MMUT region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-49430402-C-T | Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency | Benign (Jan 13, 2018) | ||
6-49430409-G-A | Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency | Uncertain significance (Jan 13, 2018) | ||
6-49430476-A-G | Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency | Uncertain significance (Jan 13, 2018) | ||
6-49430514-G-T | Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency | Uncertain significance (Jan 13, 2018) | ||
6-49430544-A-G | Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency | Uncertain significance (Jan 13, 2018) | ||
6-49430546-A-G | Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency | Uncertain significance (Jan 13, 2018) | ||
6-49430620-G-GT | Methylmalonic acidemia | Likely benign (Jun 14, 2016) | ||
6-49430684-A-T | Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency | Uncertain significance (Jan 13, 2018) | ||
6-49430742-C-T | Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency | Uncertain significance (Jan 13, 2018) | ||
6-49430953-T-C | Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency | Uncertain significance (Jan 13, 2018) | ||
6-49431037-A-G | Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency | Uncertain significance (Jan 12, 2018) | ||
6-49431092-A-T | Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency | Uncertain significance (Jan 12, 2018) | ||
6-49431101-G-A | Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency | Uncertain significance (Jan 13, 2018) | ||
6-49431148-T-C | Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency | Benign (Jan 13, 2018) | ||
6-49431170-T-C | Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency | Uncertain significance (Jan 12, 2018) | ||
6-49431262-C-T | Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency | Uncertain significance (Jan 13, 2018) | ||
6-49431263-G-A | Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency | Uncertain significance (Jan 13, 2018) | ||
6-49431283-T-C | Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency | Uncertain significance (Apr 27, 2017) | ||
6-49431447-C-T | Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency | Uncertain significance (Jan 13, 2018) | ||
6-49431450-T-C | Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency | Conflicting classifications of pathogenicity (Jun 20, 2021) | ||
6-49431471-T-G | Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency | Uncertain significance (Jan 13, 2018) | ||
6-49431526-AT-A | Methylmalonic acidemia | Benign/Likely benign (Aug 10, 2019) | ||
6-49431526-A-AT | Benign (Nov 05, 2019) | |||
6-49431528-T-A | Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency | Uncertain significance (Jan 12, 2018) | ||
6-49431566-T-G | Methylmalonic acidemia | Uncertain significance (Jun 14, 2016) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MMUT | protein_coding | protein_coding | ENST00000274813 | 12 | 32832 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.71e-22 | 0.00272 | 125570 | 0 | 178 | 125748 | 0.000708 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.229 | 401 | 414 | 0.968 | 0.0000212 | 4896 |
Missense in Polyphen | 169 | 194.83 | 0.8674 | 2234 | ||
Synonymous | 0.0118 | 132 | 132 | 0.999 | 0.00000628 | 1484 |
Loss of Function | 0.402 | 35 | 37.7 | 0.929 | 0.00000228 | 415 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00210 | 0.00210 |
Ashkenazi Jewish | 0.00149 | 0.00149 |
East Asian | 0.00136 | 0.00136 |
Finnish | 0.0000466 | 0.0000462 |
European (Non-Finnish) | 0.000476 | 0.000440 |
Middle Eastern | 0.00136 | 0.00136 |
South Asian | 0.00108 | 0.00108 |
Other | 0.000652 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in the degradation of several amino acids, odd- chain fatty acids and cholesterol via propionyl-CoA to the tricarboxylic acid cycle. MCM has different functions in other species.;
- Disease
- DISEASE: Methylmalonic aciduria type mut (MMAM) [MIM:251000]: An often fatal disorder of organic acid metabolism. Common clinical features include lethargy, vomiting, failure to thrive, hypotonia, neurological deficit and early death. Two forms of the disease are distinguished by the presence (mut-) or absence (mut0) of residual enzyme activity. Mut0 patients have more severe neurological manifestations of the disease than do MUT- patients. MMAM is unresponsive to vitamin B12 therapy. {ECO:0000269|PubMed:10923046, ECO:0000269|PubMed:11350191, ECO:0000269|PubMed:1346616, ECO:0000269|PubMed:1351030, ECO:0000269|PubMed:15643616, ECO:0000269|PubMed:15781192, ECO:0000269|PubMed:16281286, ECO:0000269|PubMed:1670635, ECO:0000269|PubMed:17113806, ECO:0000269|PubMed:17957493, ECO:0000269|PubMed:19588269, ECO:0000269|PubMed:1977311, ECO:0000269|PubMed:1980486, ECO:0000269|PubMed:22727635, ECO:0000269|PubMed:25125334, ECO:0000269|PubMed:26615597, ECO:0000269|PubMed:27167370, ECO:0000269|PubMed:28101778, ECO:0000269|PubMed:7909321, ECO:0000269|PubMed:7912889, ECO:0000269|PubMed:9285782, ECO:0000269|PubMed:9452100, ECO:0000269|PubMed:9554742}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.691
Intolerance Scores
- loftool
- rvis_EVS
- 0.2
- rvis_percentile_EVS
- 67.36
Haploinsufficiency Scores
- pHI
- 0.113
- hipred
- N
- hipred_score
- 0.466
- ghis
- 0.525
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Mouse Genome Informatics
- Gene name
- Mut
- Phenotype
- digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; respiratory system phenotype; growth/size/body region phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype;